MART-1(100-114)

MART-1(100-114) is a synthetic peptide derived from the melanoma antigen recognized by T cells 1 (MART-1), a protein expressed in melanocytic cells and frequently used as a model antigen in immunological research. As a well-characterized epitope, this peptide fragment is notable for its ability to bind major histocompatibility complex (MHC) molecules, facilitating the study of antigen-specific T cell responses. Its defined sequence and immunogenic properties have made it a valuable reagent for dissecting the molecular mechanisms underlying antigen presentation, T cell recognition, and immune targeting of melanoma-associated antigens in experimental systems. The peptide's biochemical stability and compatibility with in vitro and ex vivo assays further enhance its utility in a range of immunological and cell biology investigations.

Immunological assay development: MART-1(100-114) serves as a critical tool for the development and optimization of immunological assays, including enzyme-linked immunospot (ELISpot), intracellular cytokine staining, and tetramer-based flow cytometry. By providing a defined antigenic stimulus, the peptide enables precise quantification and phenotyping of MART-1-specific CD8+ and CD4+ T cell populations. These applications are essential for evaluating immune responses in experimental models, optimizing assay conditions, and validating novel immunomonitoring platforms.

Antigen presentation studies: The peptide is widely employed to investigate the mechanisms of antigen processing and presentation by MHC class I and class II molecules. Its defined sequence allows researchers to track peptide loading, transport, and presentation on antigen-presenting cells, thereby elucidating the cellular pathways involved in immune recognition. Such studies contribute to a deeper understanding of how tumor antigens are processed and displayed to T cells, supporting the development of targeted immunotherapeutic strategies.

T cell activation and functional analysis: MART-1(100-114) is frequently utilized to stimulate antigen-specific T cells in vitro, enabling detailed analysis of T cell activation, proliferation, and effector function. By exposing peripheral blood mononuclear cells or isolated T cell clones to the peptide, investigators can assess cytokine production, cytotoxic activity, and signaling pathway activation in response to a defined antigen. These experimental approaches are fundamental for dissecting the cellular basis of anti-tumor immunity and for evaluating the functional competence of T cell populations in research settings.

Epitope mapping and vaccine research: The peptide plays a pivotal role in epitope mapping studies aimed at identifying immunodominant regions within the MART-1 protein. By systematically testing overlapping peptides and variants, researchers can delineate the minimal sequences required for T cell recognition and MHC binding. Insights gained from such investigations inform the rational design of peptide-based vaccines and immunotherapies targeting melanoma and other malignancies expressing MART-1.

Peptide-MHC binding analysis: MART-1(100-114) is also employed as a reference ligand in studies examining peptide-MHC interactions, binding affinities, and structural determinants of immune recognition. Through the use of binding assays, crystallography, or computational modeling, researchers can explore how this peptide engages with specific MHC alleles and T cell receptors. These analyses are critical for advancing knowledge of antigen specificity, cross-reactivity, and the molecular basis of immune surveillance in cancer and autoimmunity research.

1. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

2. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis